Skip to main content

In hemophilia A, emicizumab cuts bleeding; plasma-derived factor VIII less likely to trigger antibodies

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
In hemophilia A, emicizumab cuts bleeding; plasma-derived factor VIII less likely to trigger antibodies

User login

Username

Password

Reset your password

Type	Lead	score